Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Conditions
Ulcerative Colitis (UC)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Xencor Investigative Site, Scottsdale, Arizona, United States
Xencor Investigative Site, Bradenton, Florida, United States
Xencor Investigative Site, Brandon, Florida, United States
Xencor Investigative Site, Jacksonville, Florida, United States
Xencor Investigative Site, Kissimmee, Florida, United States
Xencor Investigative Site, Margate, Florida, United States
Xencor Investigative Site, Palmetto Bay, Florida, United States
Xencor Investigative Site, Tampa, Florida, United States
Xencor Investigative Site, Louisville, Kentucky, United States
Xencor Investigative Site, Albany, New York, United States
Xencor Investigative Site, Rochester, New York, United States
Xencor Investigative Site, Raleigh, North Carolina, United States
Xencor Investigative Site, Beavercreek, Ohio, United States
Xencor Investigative Site, Cedar Park, Texas, United States
Xencor Investigative Site, Denton, Texas, United States
Xencor Investigative Site, Georgetown, Texas, United States
Xencor Investigative Site, Houston, Texas, United States
Xencor Investigative Site, Houston, Texas, United States
Xencor Investigative Site, Kingwood, Texas, United States
Xencor Investigative Site, Lubbock, Texas, United States
Xencor Investigative Site, San Antonio, Texas, United States
Xencor Investigative Site, Tyler, Texas, United States
Xencor Investigative Site, Webster, Texas, United States
Xencor Investigative Site, Richmond, Virginia, United States
Xencor Investigative Site, Wollongong, New South Wales, Australia
Xencor Investigative Site, South Brisbane, Queensland, Australia
Xencor Investigative Site, Southport, Queensland, Australia
Xencor Investigative Site, Joondalup, Western Australia, Australia
Xencor Investigative Site, Nedlands, Western Australia, Australia
Xencor Investigative Site, Sofia, Bulgaria
Xencor Investigative Site, Vancouver, British Columbia, Canada
Xencor Investigative Site, London, Ontario, Canada
Xencor Investigative Site, Scarborough Village, Ontario, Canada
Xencor Investigative Site, Montreal, Quebec, Canada
Xencor Investigative Site, Rijeka, Croatia
Xencor Investigative Site, Zagreb, Croatia
Xencor Investigative Site, Tbilisi, Georgia
Xencor Investigative Site, Athens, Attica, Greece
Xencor Investigative Site, Heraklion, Crete, Greece
Xencor Investigative Site, Thessaloniki, Greece
Xencor Investigative Site, Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary
Xencor Investigative Site, Budapest, Hungary
Xencor Investigative Site, Budapest, Hungary
Xencor Investigative Site, Vác, Hungary
Xencor Investigative Site, Chisinau, Moldova
Xencor Investigative Site, Wroclaw, Lower Silesian Voivodeship, Poland
Xencor Investigative Site, Warsaw, Mazonian, Poland
Xencor Investigative Site, Sopot, Pomeranian Voivodeship, Poland
Xencor Investigative Site, Bydgoszcz, Poland
Xencor Investigative Site, Katowice, Poland
Xencor Investigative Site, Staszów, Poland
Xencor Investigative Site, Szczecin, Poland
Xencor Investigative Site, Warsaw, Poland
Xencor Investigative Site, Bucharest, District 1, Romania
Xencor Investigative Site, Cluj-Napoca, Romania
Xencor Investigative Site, Lutsk, Volyn Oblast, Ukraine
Xencor Investigative Site, Ivano-Frankivsk, Ukraine
Xencor Investigative Site, Kyiv, Ukraine
Xencor Investigative Site, Kyiv, Ukraine
Xencor Investigative Site, Lviv, Ukraine
Xencor Investigative Site, Lviv, Ukraine
Xencor Investigative Site, Lviv, Ukraine
Xencor Investigative Site, Uzhhorod, Ukraine
Xencor Investigative Site, Vinnytsia, Ukraine
Xencor Investigative Site, Vinnytsia, Ukraine
Xencor Investigative Site, Zhytomyr, Ukraine
Study leads
Mark Osterman, MD, MSCE
Study Director
Xencor, Inc.